Background: The most frequent site of recurrence of differentiated thyroid cancer (DTC) is
cervical lymph nodes (LNs), which often necessitates repeated surgical interventions and …

The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …

The main clinical challenge in the management of thyroid cancer is to avoid over-treatment
and over-diagnosis in patients with lower-risk disease while promptly identifying those …

Objective: The aim of this study was to evaluate the association between this characteristic
and outcomes in patients with lymph node metastasis in a Brazilian cohort. Subjects and …

The natural history of papillary thyroid cancer (PTC) is such that many patients reach normal
life expectancy after total thyroidectomy and radioiodine therapy (1). Still, a large number of …

Background Lymph node metastases are relatively common in thyroid carcinoma, but
retropharyngeal nodes (RPN) are rare. Management may be surgical or non-surgical …

Background We identified factors predictive of outcome for recurrent differentiated thyroid
carcinoma (DTC). Methods Fifty-seven patients with local (LR), regional (RRec), and/or …

Background Although most thyroid cancer patients have an excellent prognosis, 10% of low-
risk cancers and 25% of high-risk cancers recur, with mortality rates in excess of 50% at 3 …

Thyroid cancer is the most common endocrine malignancy. Differentiated thyroid cancer
(DTC) with the two subtypes, papillary thyroid cancer (PTC) and follicular thyroid cancer …

Introduction: Papillary and follicular thyroid carcinomas are the most common thyroid
malignancies and are usually indolent. Lymph-node involvement increases the rate of tumor …